Vaultly tag

Thalia Therapeutics news and market signals

Public Vaultly articles where Thalia Therapeutics appears among the affected assets. Premium market intelligence becomes searchable here after 24 hours.

Thalia Therapeutics Secures, 3.1M and Acquires Sanmirna to Expand RNA Pipeline

StartupsPremium

Medium 7/10Thalia Therapeutics Sanmirna Therapeutics

Thalia Therapeutics Secures, 3.1M and Acquires Sanmirna to Expand RNA Pipeline

Thalia Therapeutics has completed a, 3.1 million funding round alongside the strategic acquisition of Sanmirna Therapeutics. This move integrates clinical-stage microRNA technology into the British firm’s existing oncology and cardiovascular portfolio.

June 26, 2026Published 3 hours ago